HomeCTXR • NASDAQ
add
Citius Pharmaceuticals Inc
Previous close
$0.69
Day range
$0.67 - $0.72
Year range
$0.63 - $2.48
Market cap
15.89M USD
Avg Volume
425.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 3.94M | — |
Operating expense | 11.60M | 15.55% |
Net income | -8.22M | 15.84% |
Net profit margin | -208.43 | — |
Earnings per share | — | — |
EBITDA | -7.87M | 21.58% |
Effective tax rate | -2.89% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.72M | 601.89% |
Total assets | 140.39M | 16.31% |
Total liabilities | 46.92M | -9.39% |
Total equity | 93.47M | — |
Shares outstanding | 22.38M | — |
Price to book | 0.19 | — |
Return on assets | -15.56% | — |
Return on capital | -24.18% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.22M | 15.84% |
Cash from operations | -13.01M | -175.27% |
Cash from investing | -4.40M | — |
Cash from financing | 20.88M | 711.09% |
Net change in cash | 3.47M | 261.22% |
Free cash flow | -18.07M | -1,853.01% |
About
Founded
2007
Headquarters
Website
Employees
23
